Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNexus Gene Lab (BGLC) Dividends Paid - Common (2023 - 2024)

BioNexus Gene Lab's Dividends Paid - Common history spans 2 years, with the latest figure at $2429.0 for Q3 2024.

  • For Q3 2024, Dividends Paid - Common fell 5.93% year-over-year to $2429.0; the TTM value through Sep 2024 reached $9057.0, changed N/A, while the annual FY2023 figure was $8877.0, 13.9% up from the prior year.
  • Dividends Paid - Common for Q3 2024 was $2429.0 at BioNexus Gene Lab, up from $1834.0 in the prior quarter.
  • Across five years, Dividends Paid - Common topped out at $2711.0 in Q1 2024 and bottomed at $1779.0 in Q1 2023.